Achilles Therapeutics Stock (NASDAQ: ACHL) stock price, news, charts, stock research, profile.
You can purchase shares of Achilles Therapeutics (NASDAQ:ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Galectin Therapeutics (NASDAQ:GALT), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).
Achilles Therapeutics has a consensus price target of $2.83.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $1.12 last updated December 27, 2024 at 5:02 PM EST.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.